These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9696415)
1. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans. Mourtada M; Smith SA; Morgan NG Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415 [TBL] [Abstract][Full Text] [Related]
2. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets. Mourtada M; Chan SL; Smith SA; Morgan NG Br J Pharmacol; 1999 Jul; 127(5):1279-87. PubMed ID: 10455276 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan. Chan SL; Mourtada M; Morgan NG Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145 [TBL] [Abstract][Full Text] [Related]
4. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080. Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338 [TBL] [Abstract][Full Text] [Related]
5. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion. Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151 [TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines. Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109 [TBL] [Abstract][Full Text] [Related]
7. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release. Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740 [TBL] [Abstract][Full Text] [Related]
9. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery. Zaitsev SV; Efanov AM; Efanova IB; Larsson O; Ostenson CG; Gold G; Berggren PO; Efendić S Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568 [TBL] [Abstract][Full Text] [Related]
10. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets. Chan SL; Pallett AL; Morgan NG Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462 [TBL] [Abstract][Full Text] [Related]
11. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells. Høy M; Olsen HL; Andersen HS; Bokvist K; Buschard K; Hansen J; Jacobsen P; Petersen JS; Rorsman P; Gromada J Eur J Pharmacol; 2003 Apr; 466(1-2):213-21. PubMed ID: 12679159 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Chan SL; Brown CA; Morgan NG Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024 [TBL] [Abstract][Full Text] [Related]
13. Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Sjöholm A Diabetes; 1997 Jul; 46(7):1141-7. PubMed ID: 9200648 [TBL] [Abstract][Full Text] [Related]
14. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells. Chan SL; Dunne MJ; Stillings MR; Morgan NG Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123 [TBL] [Abstract][Full Text] [Related]
15. Imidazoline RX871024 raises diacylglycerol levels in rat pancreatic islets. Efanov AM; Zaitsev SV; Berggren PO; Mest HJ; Efendic S Biochem Biophys Res Commun; 2001 Mar; 281(5):1070-3. PubMed ID: 11243843 [TBL] [Abstract][Full Text] [Related]
16. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat. Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667 [TBL] [Abstract][Full Text] [Related]
17. Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery. Zaitsev SV; Efanov AM; Raap A; Efanova IB; Schloos J; Steckel-Hamann B; Larsson O; Ostenson CG; Berggren PO; Mest HJ; Efendic S Ann N Y Acad Sci; 1999 Jun; 881():241-52. PubMed ID: 10415922 [TBL] [Abstract][Full Text] [Related]